Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Ureaplasma parvum serovar 3 str. ATCC 700970, ATCC 700970

>UU192 conserved hypothetical
MYIYYNKTSLNDTLIFLKNNQQYDHQVFLNDDLLLFYHGDELIGLNLFNA
SEYLKNLNEGYLYPTTQLIQKLSDLIKIKLSLDNAFKGFVVGKILEVNLI
PNTHLHICLVDIGDQQIQIICGAQNVRIGLKTVVATPNLLMPNGNEIKKS
KLMNYDSFGMLCSQKELNINNFNSQGIVELNDEYQVGQLFTKVYSNL
>UU350 conserved hypothetical
MNPKTRIAFIADLINDAQNVVDVGSDHAYLAKILLVNNKAQHVTNIEVNQ
GPLENGINNLTKNNLLKRTTNILNDGFKGLILEQTFDYCVIAGMGATSII
EILEQNKNQIKNYILQPNTQSYKIRKYLNNHSYQIKVEHIFVEKKIFYEI
IICSKTINVPKLIEKDYYISSQMHKDSLNLYFKFLKRRYEYLKALDISLV
SENIVKEYEYIKEFINEKNGY
>UU383 conserved hypothetical ATP/GTP-binding protein
MRTIAIVGKPNVGKSSLFNRILMRRKSIVDDQPGVTRDRIYDIGNWLTRS
FMLIDTGGIISSKDTYQDNINEQVLFAINEANTIIFLVSAKDGINNDDKK
IAKMLKEKAKDKKIILVINKIESEKYYLNEGELYSFGFGKFFKISAEHGI
GMGDLLDELVKDMPIQNNLEKQERFKFCIIGRPNVGKSSLTNTILGEQRV
IVNAEAGSTRDSIDNDFNYYNKKYTIIDTAGIRRKGKIVESVEKYAVLRT
KKAIERSQLILLVLDGSEPFKEQDEVVGGLAYNANIPTIIIVNKWDNIIN
KNSHTMEMVKKQIRSQFKYLSWAPIVFVSALDNKRIHTIFEAIEFVREQA
MRKIATSLLNDVVIKANAFQEPPPFKGGRISISYIVQVQSQIPTFVLKCN
NPKFLHFSYARYIENEIRKAFGFDSVPITLYWQDKNKKLRGE
>UU122 conserved hypothetical
MLGLGILVAYLSHFIRFNFLAFDFSLFTLVYLIYKVKYRFVYLVTILLSL
ANLLHGSPSWIGTMVLSLNNLFFVTMVILFKKLFIPKRPKFYLNLWVLVL
SSFLTTVFNVIMNGILYTPLYWYTFKITPTLNFLEVQKIYEKHPTLFLLN
IKSYWLGIIALYTSFNLIKNIIISFISLTILKIFADKKTIITY
>UU051 unique hypothetical
MKMIMITMVVFMNHNYNIQITLLENKKFNIDNGLLYVNVNEENTWQKIEN
NTVLAYEIILLKIVDDDYKKTFYLFLKNTHISVLNNIVKIQALNDLHFFI
KDGLNKKNNHKKELVDKYKNITNNILELEAKQQLGLTLSEFLDLDNLKQE
QYITNMQIRLNLVEYKKDEK
>UU030 unique hypothetical
MNLKTKFFLKVISVIAPIVIIPTILANCAHINSNELDNAKTNLKGSVEVV
NINPYKTKQMLASNINKEQINSYFIFIFNLIKTNQKIEEKILDKNDYEIL
NWAANDNDGTLGINIYIKTTKQSYLINTKPVFLTDKQNNYLQELKYKTPA
VYSIDEILKFSNNPYNLIHNNPYYREQLLRAKIYFNQNEANVDDSKLYMN
KIGYSEFGSDVQKRLENAFKIRYDEQNIYQINSPQILAKETKTLTSYIDK
KTNNNYSINIELIKKLIQINPFGKLPKNFAQLINLIKKEEYPKFLTITKN
ESVDNIVVKDIYYRIIDRYAKLEFILEIYNKKTKQTVYLSANFNQKNSGL
LKNEDYFQYIFDRTISLDLLTTKDGKNVELNSGTGWIVDRIIDDSLPKNK
IKLLIATNNHVMGWSNLAISKDNRMKSRWFNKQEYINYLENNAGFISSNI
YEDKDRYQYLLWGTAPLKSPVSNKYNSLSGISFSNLAKVYNITNQNFINR
AWYIPQLSANGIKINENLRTWYQINQEDIKSIKNGTLDFVLVPMVFDIED
IKEKLPNYYKVLNTKDEANWYIGLGNSKKYLPQLQLFSGGYPGDVNPNSS
AIVSWRGSKSYGSLIQAFDREIKNESILDYYGPKQINNIDGYQKVGEGYL
NKLFNVGTRVITSDEIGDLGSGSSGSMIIDSNFNLVGIHFASLNSRAYGA
PNDSMIGNLFVAQSQDLSGDIDVRAAVIKKLKAENIYTYKLNPKVSS
>UU380 conserved hypothetical
MKKTLVLYARVCPTKSFHTQQIFEAFQKQTNFVCVNLDANQPFDVSKEQE
FILGFDRIILLFTLNWYNIPWSLSRYFIEVWRTFPFSLENKEVYKIITTG
ANQDFYEKKDPNINNISVEEYLNNVNGMLKKLRASIQKSFYYYGAINQDQ
MRLNQFVNELIKYFKNQN
>UU297 conserved hypothetical
MNNKNNGMHLEVLINKSISLFNLQYQAFFKKRCVDIIIKNIDNSYVQGKI
KQKSETDYYGFYKGDYFDFEAKQTNKNSFLIKQIQPHQLAHLYLIHKNSG
FSFLIICFINYNLYFIITFQQLINYYQKTKRKSIPFQWFKDQCIELEIIF
PGVINFKKMINDLKLKYYDD
>UU035 unique hypothetical
MRKFNKMLSNKKFLDLDIIKESFDNYLSVGTSRSTKKLKTLHGSIAKDLE
ELLGKEYNIKSQGYRDDKEECIDGRYYNKKVDITIKNNGKSIAGLAIKFV
MSNYSQNSNNYFENMLGETANLRSNSVPYFQIFIIFDKVPYYKSDGVLQK
YDNISNHNLEKYLKLSDDDPKVYFHTPDKTLFILLSLKEISEEIKNKKDY
IRCYKEIMNDEDLLSYSNKIDDLFGNSIILNNYEDFIKRMCALIIGYQKI
KT
>UU390 unique hypothetical
MNLKSFEFLKGDAIVDNQIKKAINTSLIKASFSCAIMCILVLIFGFLMRK
YLFYFSDASSLIISSRLIFQIITIIVATLSIVYFIVHLIIYFRQRNNFLA
PKFAWSIILYLLDGITMCFMISYVAAIVGLDLTLIAIGISLSIIVAMGIL
GFIMNHKIAFKLGIANIVLFTIATIGSIILLIVFFTTRYNHTGFNKGVII
ADIVLSIIWLLALSIGFASTIYIIKVMAEHHNLDNKKIMRDFTTWNSYLL
FASFNRILLYVIRLFLLFKRV
>UU016 hypothetical membrane lipoprotein
MKKSKINKKILFASLAGVVTLTSVAAIAASCNDSNKDDGKTNKDGNYISK
LSLEDFYAKPAGDDSLGYHRTYNSLYDDGARMLGLISFSHSIPIKEYFGS
SSDKKDLSAVLIDDKFSGTVGKDRIASVSYRVDQAAFLTGIAAAYYLNAN
QKTFAADGKLTWGGYVGLHFTSTSTFIQGFKLGVQWANEKLKDKEINQED
ANGSKKKWMNVEQVFASKYVAGSFKPDEEGATNIINDLITKKADVILPVA
GPQTNLATSIVSNATDPSVIIGVDTAQELDDVTNRKRITNKTVNDGKTIL
FSIVKRVDLAMKGAIENASKGAQLTNDINKDAYKLGTHTEASLDKSTYVD
DTPLVELSNAGRVYLEQAAKLAGLKAITYAQIVNVIQNEELFKLLSTKGT
TKLEDLATKTSDGWVLKDSEKNKSFSELQKLLGGEVYINESDKKLYPYSL
TGSSYLEEDPKKRSASQEFKKYWDAATTPEAKEKLAKVVLGQNNAVLKDK
SFSESAYNGLAAFYKSKKIIIPKI
>UU305 conserved hypothetical
MQKKYIKNTLGFDTNLFIYQDKKMFNYSIDTILLANFISLSSKTKKILEI
GTNNAALSIFLALRKEDIKIDAIEIQIEAINLALLNVSQNHFEKQINIIH
ADFNQYWKDFDKSENNKYDAIICNPPFYKQDKIIPSTKNPLKTLALYEIT
LNFEQIMQGCAKIIKQKGNLAMVIPTTRLVDLLEIMRKYQFEPKRIKMIY
PRIYEQSNLVLIEARYKSGWGTHFEPNLYLHYEDKQNHQYTEEVLNWYKP
IKFKK
>UU502 unique hypothetical membrane lipoprotein
MSDKSTLKQENTIEYPVVGALRRASASVLDYIFISIIAFLLSLLVFINSN
FKISDIFVNNDELAPEPWRLFLMGIIAFFVYSTYYIIIPLFCKSYTLFRW
AFSIRMISLVKQNDKKILFIALIKHSLLTWLIFTIINLLAMGFCFVFADA
SFKSIQAMNETELKEYYHQIKDLKAYVQSILSLKINDNFTNTTTMAILSI
LVKSLYSIMGLVSCIIVIHMFMNSKKRALHDQVAKVVLLWMHYEKPKQAP
KHKTKREVEIQKIDNLIQELDKI
>UU520 unique hypothetical
MVFLYKRGRFNLEEQKQMKVIKKSDSYFKKNLTVFRTLLELLKESSPFIA
ASVFTGLSLILIVVIVAHHKDIGAYAATSISYLTIFQLSFLQLGTTFGIV
FAIWSKRSFKDGKYKFEPTNDTVNAASFYSFIFGLVVLLIYFTTSYIYNH
FANDHQNTVINQSVGSAYIVSGLAVVGLAPLRNYLLMLIRSTKSINVLLA
IVLDFCTWTTALIAAFLLGSYSVLNYWGYGLGMSIGFVFWTIIIGMTTIE
KAQIVLRPLYISKRLFVLSIKLLWIQTILSSLKSVGKMFILLITFVVINS
RVVGSSLLDFQSTRILMYQSMIFIQMLNLGLSDFLFYLYQKQEVRDCRYH
SRQLFFWVFILGILFALITSVIFGFSVKQLVQLYTSEQSPSYIFLEKQVP
EHFYQSLRKILINDEKLLDIITSHVNIGRQEVVNALSSNDKNIWLPMAQK
VIDPIWKLGDKFETIYQMKNPFTHRFVDISASNIYSYLIKNNAYILLSFF
CTFFSFSSILSRYVGLIARRQRPPYVMIVIQLVMVAFTSGFGLTHQSDPH
FIGLMAWSFPLFISSIFILGYSTYKILRIYRKYLKNHKYNDEKLSIMPKK
QLEQQIKVRQN
>UU509 conserved hypothetical ATP/GTP-binding protein
MAKINFLSLGGQDERGKSCFVLEVNDDIFIFNAGAKIPTSDVFGVNMIVC
DYSYLEKNAKRVKGIFIGTPTFNNVMGIKLLLGQVGYKIPIYTSPIGAIV
IKKIFEQKVNNKKIEPNIIELDPISDKKIGSIYVTSFKVSNSMPHSYGFV
LKTSDGAIVYVDEFIISNDKNKTFDSQINLLNNITKNNTLALIVGMGQAG
NPYFTAPNHKNKAFYEAALQNTKNRLIVGCYSNDAYSIFTLATIAKQQNR
PFIVYSNNFINTFIGVLKLKLFNSKNLISLPVSEINNSKNAIIVVIENQD
TLFSKLNKILHNEDKYVNLSSDDQLILGVVITPGFEMLAAELSDEVGRLD
IPYKALPKTVLPMTQSDEDLKHLINFLQPKFLIPINGLYKTEVKFSSTVT
TSWIKSDQIISVSNGELFTIEDKVLNPKPQIIELEDKYISSFDALDVGAN
ILFERSQMGENGVINLIVIFDKQFQKLFNYVEFDYCGVVNNDAQIKEIEE
TFKKRMGECLVYDERKRLILKDTKANLKRLLTKLFEKKFNKRPLVLPTVV
DCYKTK
>UU598 conserved hypothetical
MVKNFFIKDPIHGLITFDEQYEWAYELIKTKEFWRLNNIKQLGSSWSIFP
SATHTRFTHCIGVFQVTRKLLDSLKFIKSDTHDLINNKKIVCAAALLHDI
GHGPFSHTFEYATNYNHEKIGQMIITNPKSEINKILIKHNINPVDVANII
DHKSKKMWMQQVISSQIDADRLDYLPRDSHFTGTKYGNIDYDNIFKKAIV
FNDQLCFSKHSWNALENILISRWSMFENVYLNKTPTTYDILMKKTLARVH
FLYQKQKKYIFKNSQLLTILKPWLDNESWDITTVQNLDDYSFTALMRSFA
NEHDFILKTLATNWLQNKDFVTFEYEYGKDKSKDQKIIHKKYFYETITSN
KQIYDFNEPVFLYTENKNNDIKLLKLEDKSLIIAALKSIKQPRIKKWIFY
YKPLK
>UU468 conserved hypothetical ATP/GTP-binding protein
MITNKKCKGCGAFLNDQINTIGYTPKINETKTNLCQRCFKLIHYNKLEKV
STNLNQSIKETINTLNFSNLQIFAVLDILDLEHTIIDELKEYQNKIIFLV
NKIDLLPQRYNSELVNENVVKTLINHGFIDPKIIYVSTHSNTSLKKVMDY
IKNATNKKQKSIFFGKSNVGKSSLINALLALNKIKTKLTISSYTNTTINL
NKINIQEHQILDAPGVCFDENILNYVRDEDNKSIMISYGAKAINYQINPQ
QALMISGLVGIQYLKGQKTTFTLYVSSQLDIHRCKLENFIMNFNKRYLLA
KFNYLNQDLEFVDHLITLNKDQKTNICIAGLGLLVINAHAEQICIRLPKS
VGLKVAKYAII
>UU012 unique hypothetical membrane lipoprotein
MKKLNKKVLFLAIGSVFALGTIITVATSCTQKSTLNYSQFYWTSPTSDDD
EGFQTKYKSMASDGKRALLMPGYQHPERLQNALVNDKFDPNLIALILDGV
YNNDNKAEFYKGADRVADVYFKVDEAAFLGGIAAAYMLNSNQAVFGADNK
LTWGGYVGINAKNTTNYLAGFDLGVKWANEKLKDKNIKQEGTQETKKWIN
VEQVYASESSAGGFQSDSANAKKIIQELITKGADLILPVAIPQVGIAVTE
AIATTSHNVGVIGVDVEIENDQAINKKTDKFINTHLSGNKNGVIRFSITK
RLDTATIKLLENAIKGESLSKKSDQIVIGSEIDPKDKYKLGVNTVGNLSD
GVVGISPSAYHYVIDAFNLAQTNQSDKVSTYDELVNKITNDDLFKTLDKK
PVVDGYLDVKKETDNEASLLNNKTIDPRVNGGTFYKSAKGTYYFYPVAKS
TYISNTSSKKFKEIWDNTKSNDEKQALIGLLLSYAGAKVKDGGYSENTYN
GLKEFYAKHGIKIPQL
>UU570 conserved hypothetical
MENTKKSPTYVYALGGLEEIGKNTYVVEHEDEIILIDAGIKFANASLPGF
DGTVANFDYLIKNNHKIHSLVVTHGHEDHIGGIPHILRHVKIKTIYAPTL
AAKLIERRLSEYKDIKPPRIIVFEDESMYKTKYFEVDFYRVCHSIPDSFG
ICVKTPNGYIVTTGDFRFDFATAGDETNLAKISQISNRGISVLMCESTSA
EIPGFSESERYVIDNIRDYMVNIKGRTFISTFASNLGRVEEIIAIAVGLN
KKICIIGKSMEANIKTSRKLGYLNVPESSFITHKELPFYKDHEIVVILTG
SQGEKMAALNVMANNNHSKITLKPSDTIILSSNPIPGNYAQVEAMVNKLY
KLGLTVYENSPNKKIHASGHATRSEHQLMIKAINPSYLFPIHGEYKMFRA
LKQNAVDQGFDKDHVIIAPNGQKLQLLDGVLSHTNIYVDAEPKFINGYEI
SSKISKLLSERVVLSSDGILNLVLNADFKKAKLNSAVSISTRGCFFAKES
TNLINKISNVAKSSLEEALAKKEFDEKKLKEIVSGNVKSIVWKWRKKNPI
INVTIINNDLVEQFRKDNNYVEFIKQAEVEEIEQEVDIDDLISNGL
>UU296 unique hypothetical
MSNYELRRRIIMSNIDVKTNFWKLNQKNKKILFRVLGYSSLSVTIITPLI
YKISYNKQYSFITKSIRELKTIDTNFVSSYSDFYILQKSSISNDLYNYNL
INNYHDFEKLIKNDLNFDKYNSALIYEKIKVSLLEKYNENFFKNNDLLYV
SYNSLDSKYFLTSILSFDYNNLYLPFLNTKSIFNDEYDNKNFYTDSALST
TKTEVKFFSINKKYNIKLKQIKIYSIETAKDLFLYKNYVRKNNKPI
>UU226 conserved hypothetical membrane lipoprotein
MRICLEKIMRKIKLNKKIILASVIGIMGVALVPIALVACSQNKTKSDSRN
LTLNNFYGRPSSDGDDAYQAIYASKIQDGARMLGLISFRHKNPISKYFNS
PKDNQQVSAVLIDEIYDLQTGKDRIASITYRADQAAFLAGIAAAYYLNSN
QNVFGKDNKLTWGGFVGIHLPSTTRFIQGFKFGIQWANEKLKNKKVKQTE
NNEEKEWINVEQVFATNYQSGDFSPTSDKAKAIVNQLVSNNVDLILPVAG
PQIDYATTAAAESSKPIVVVGVDTEQELDDNTNKARISENNKSLANGKTI
IFSIVKRLDLAFKGALLKASEGAQLTNDINKDAYKLGTHTEASFNKNTYV
DNTALVELSKAGHQYLIDAIKLSGLKEVNDYKTIVEIIQEDPLFKLLSQI
GTKKLDEVATKSQQGDWVLKSEYQDLPFIQLQKMLGGLVYVDQKNELYPY
ELSNSFYLEKDPNKRQASRAFYNYWNAKDANQINLVKIFLGQSVDVLKDK
SFSESIYKGLEEFYKSKNIIIPKLY
>UU269 conserved hypothetical
MRLRNNANAPLYLKSQHEYIINDPHLLKDNLGKIFKNPELPLYIEIGMGK
GDFIIENALRNQQINYLGIEKFPTVIVKAHKKALKHKLDNLAMICFDANK
ILELLNSESVDKIYLNFSDPWPKKRHAKKRLTHPCFLEKFAVILKQNALV
EFKTDNENLFMYTIYDVLLKDLTKYEILFLTYNLYTLVNNVELLKNIPTE
YEKKFVMQGERIKKVNFRFLKNNQ
>UU214 conserved hypothetical
MKLNNHNLKEIYSLSLNELKEELFKLGLKSFISKQIYSWIYQKRIFNFDK
FSNIAKNNVIILKENFSNNLLKINSYQSNSDGSIKFEFLTDKNLIINCMI
IKFKNGFLIKINPFGINFKKEIINLSTNELVLQILLIQQFLDQRKLGNIT
NVIIKGLQDSLLNMDVVSNFINIINNENGLNIGKRKIAVWTSGINVDLIK
WGQLQNQIELIISMNASNSLIYQKIMLKKLNQNWSFLKLIEQIKAYTKIT
NNRVVLEYLLIDKINDDLNYANELVELLKNILCYVLLIPYNLNNYRTSAN
LDDFFNILSVNKIRISKRIRKSNDLDISFKQLKIKE
>UU217 conserved hypothetical ATP/GTP-binding protein
MVGDDVEVELIGNTYLITKIYERYNQLIRPKVANIDIVLIVVSIVQPDLN
TLSLNKYLAFYEARNIKNVLIGLSKYDLANNHLKQKINKLILDYKKNNYA
VFILTKENDILLLKEKIKSKTLCLAGNSGVGKSTLINKLDPSIQQRTQEI
SHFLNRGKHTTTSTKLISFANGFLVDTPGFGNLEVNLTKNEMANAFNDFA
NYARFCKFSNCLHIEEPECAIKKAVDEKLIVNWRYDDYLKIIKELPNDVL
KIKTRAQNRKCK
>UU569 conserved hypothetical
MQYKMLVIDLDGTLLTKTKNISKANLQGLKKYISLGGKVVLSTGRSLENT
LKIVHLIHDQIKELIQYISCFNGSYIYDVINEKVLFESTINKDIVNEIYK
FSLKHGLGFWPYNQRFMQTHFLDVYNINYKFLLQLHHTKRKVCLNPIFNK
NDKFYKINILPSNFVKKLKHEVIDQLIKEFSDQVNISFTSKYIVEVTNKN
INKASSLRFIANLYQINLDKVATIGDSPNDIPMFKISGLAAAARTKSKTI
IEHVDVIINYKNNSNSVALFINNYLLK
>UU207 conserved hypothetical
MKTIKLDLFQKMLYAGAKILEIECEYINDLNVFPVPDGDTGSNMKTTTAG
AIIAIKEIEISNFSQLAKIFSRGLLMNARGNSGVILSQIFRGFMDALNND
AYEVSIEQLKQAFNGAKEKAYASVSTPIEGTILTVIRVINERISERQNFD
SVEDLFAFVTKEAQIILERTPEMLPSLKEANVVDSGGYGLVSFLKGMYQS
LTNTFDEKLIIKNEEENIKSKTKPLDLEIIHKEKEEGFGYCSEIILSLRK
KIIPNSPSKSFFEFEKYKSELAKIGDSIVAIQDEDLVKVHLHTLTPYKFL
QLSQKYGEFDKIKIENMTNQFYESLERKGLTTKKENKLTLSMEQKIIATV
PSEKFKKMFIEEHGIDNVIVTETEGAPSIQRFVDEINSTNSSQIFIVTDD
SNIVLAAEQASKIVAENNILVSVIGAYNVFETLLAISHFEQQNDYRTNFK
TMNKIVKKARSGMITTSIKNVKYPHITVNKDDYIGIINKKIIASEKNAYD
VLLKTIEMLIESLKKPEICYIYYGINASQTDVHQIEKYISEKYGIICDLR
YTGQSLYHYYIGIQ
>UU083 conserved hypothetical
MNVALELINLLKERRLRLSVCESASCGALSSSIGEVAGASSVFAGGFISY
SNEVKIKLVGVSEKTIFKYGAVSEQTAKEMCLQTNQKFNTDIAISITGNA
GPQGSENKEVGLFYIGIAIKDFAIVKKVTLNSNERTFNRFSIAWEAISYL
IELIKK
>UU156 unique hypothetical
MRSKQWHLSTQDANLANKKYDYIYFRGVNQLYLKRLKKSSNKFFVYKKCK
IVPRMISKHLNNDHLINVNDYVPLTKEFIKKSVEKEVKHYLRFISYENKT
KQMPELINFLEKSLEDKLFIVAKDYDPLFSVFLRYYIQSLIEKYINELWI
NEW
>UU490 conserved hypothetical
MHFLITNEVKKIFNDKLYSQRFKQITDLVSTKLNIDKKRFFECHFVDEKT
IQEINKNYRNKDYITDVISFAFDDGEIITPLLGEMYICYQKVVDQASQFA
HSFERELCFLFTHGLLHLLGYDHIKIEDEKIMFALQDEILNELKITRNIN
GARND
>UU384 conserved hypothetical membrane lipoprotein
MINNLFKTKNYYISFLILATSIACCFYYNNFWILIVNICQFYWLYSIKFN
YKIIILIIIFSALCIILCLLIHKDFNIHFLVINIEKKYNYSLRTQILIYL
SKKYSNENTLMLIKLMIFNEKINSDFKQILYDLNIAHLFIVSGLHLNLFI
LIINKIFSKRWPKTSFLIGILFLLFYGYLLEFSIGFIRVFIMHILSIKFF
QKISKMDKLAISGMLIGCLSIYNLSILSFIFAYLALFCIYLINIFIKNNS
VLKNIYINLYILSITFVISINLNQKINFLSIVFGYVMNLPILFVYQILFW
LMFIPHFELILDLFTNTLVKSIYFISEIDASILIKAYVKIVTIFYTTIWI
TTSLWIYYKKILKKV
>UU195 conserved hypothetical
MKLCDKEYILSVIATPIGNLEEVSERVIKCLNEAYVILCEDTRVTAKLLH
LLNIYDYKKLISYHNFNEIQKLNEAINYIKKYPTALVSDAGYPTISDPGY
KLINECHQQNIGIQVINGPSSLMHALVASGMCSQDFMFLGFLGKTQKQRV
EKLKLYKNLQTTFVIYEAVHRIEKTLMDIYEIWGDILIFIGRELTKKNES
HYYGYLSQLPPITEKGEFVIVIDNKINQDVIKNNNINECLIKIRDLMKQN
FKLKDACKEVSKSSNFDSKELYKLIINQK
>UU340 conserved hypothetical
MYKLIFNLCIYIKNKGKFEYMVENKFLKQIKEGEQIKIEIKGLDKFNNFD
EQNYGLNNISPQIRWSPVLETASYAVAIIDYEAVGGAPFVHWYALNIFEP
ELALNVANLGYANLYQGENSTSKHFSHSILDANYQTDIANNYFPPCPPNK
SHKYEIKVYAVHHKLSTNRNNILYLDDFEAKLNEAKIIATGSTYVCAPQI
SFEDDKLIIGSLEHKHPYLFANCENEYHVIEDVIVTDINKNIYSENQLDN
FKDLEQAKIKIIDSSDALSYAVIITSNHLFKKFGRPVVNYAHVIEKKTNK
RIKFNNSYKLNHAFSEISPSKYDHLGNELLILEDKDANFESGLFTIHVFG
LNKKIKYLNKIDSVANSISDLFEMISGSVISYKAKLFK
>UU417 conserved hypothetical
MQKDLLTKLIEQTYGFNKITIFVHTNPDCDALGSAFALARILKLNTFGTR
VKIVGVNALNPNDFKNFFTFDPNEVDDEFIKDSIAFIVDTANQERVLSQK
HRLAKKTILVDHHVKTITYTDLEYINDQSIAACEMIAYSLMHTNLNFDLK
TLNYLLLGITTDSNRLMYDKVSDFTYEIMSWFFKNNVKHYQIYQQLYERN
LNDILFDNELVKTIKTQGQVAYLNIDPQWNQKYHFTRWGDKVYLLSNIKN
YPIWFIVYFDENTNTYKVSLRSNKYKVRLVASQFNGGGHDLAAGCSLTNI
DQLENLLSALDALIKNKIVVD
>UU085 conserved hypothetical
MGYLIAFIILLILFVLLITIVPVVMVVYLKKKQLKLTFVPKSQTSFKKIV
QKTKDLEEECEDLNNKNNELKKAISDQNLQIDLLKKNNENFLLNATSLTA
EQAKKELFNLLKIKFKKELAQEYAKIKHEFNEAQEIYAQNILVETMEQIA
EPLIVERSLFNIDIIDENLKGKIIGRDGRNKAVFENEGGVDLIVDRQQPI
VGISTPNPIRREIARIVMQKLIDSKNIDINRIELLFKEEREKFEKKVFEI
GKNVVEQTLGFFDLPEGIYSYIGRMKFRNSYGQNILSHSLEVAEYAERIA
KLINIDPIKAKKAAFFHDIGKTIDFESDLDHVEAGLLIAKKFNLDDYIYN
AIESHHNKVIPTTIYGALVKIVDTLSAARPGARVNSYDEYYSRVKELETI
CMRFEGVKSAYVIKSGRQLRVIVDSNLVSDEQLELLGHEIKVAIEENDLL
TNYKIKIVLIKEKRISIDTNIIG
>UU555 conserved hypothetical
MVLIEKINEQDINTVVAYVVAFRKKLYPKVDHNNLPKELVNFKQTYIINP
LGIWFSVFLEDTHELVGTISCHEYDYRYNNLFYLDRSTKTSEVGKLYIDP
LIRRQGIATRLFNALKDQAKKQGIKCFYLHTHHHLPGAREFWLKMGFKIQ
KEMTLEDDGQDIIHMTLEL
>UU322 unique hypothetical membrane lipoprotein
MLIILMNYLKKLNNKKINYPMLKKQNKNKEQHWLEKHLRQKTGLIISWSI
IFGVLVLLSIGFGLILHFFNSNNLSIQLSFIINLNKYLVNITKILDYIGF
ALIYLPIIFLLGCWITGINGVHESLYYHVFIWLFYFISVILLIITICLSI
ATHIYY
>UU392 unique hypothetical
MLKNYFQSSWLYTTFLSRLVLFKKSTYFLVGISLFVNLIFIIINGLNIAN
NIKTYLILFYLFTSINSLLTIVFSTIKAINLFKDLKDEGIEILVFSKSIS
RKNIIFTKIGFLILNIVFWSLITYILNIIFYVVNIKNNNGINFFYLYAFF
NYYFCGLIFASIAALIVSRWSNKVAMIIPISCFLPFLIAGGVANLYSTSK
INQVAKYMNINYDKYDSNTILDVEKFYLNNHNDEVYLITKNLNNPQFSKR
QNYFLKAAFDHAKNASTFFHVLSWLSVPYQLNNSFYKNDIDPFSVNSQHE
NYLDKYFNYHGLESKLYDYKLNKHPHLPQFNINENQKEYFVPGALKNTSQ
FPTLENRNLIYARENVDRFDVNFIEDDNLFSSTNDFVGELKWAVIRNTLE
SKVFNNFAKKFYDNFDEDIDKPQIIAAYNDVINEQSSINFSTIVDENSIL
FAKKINNYYVKNLVEKKIYFIVALMYYLYFNEERWNLLEKLLKNDKVINF
YRPSSIRINVNNYAYDIGGIGSYELMKKVVNNKTLYRYQLQKSNNYVFQT
AKEVYSIKRADQIVNKNYYWLIWILFSTILIISLALIYLKRDYK
>UU526 MBA N-terminal paralog
MKLLKNKKFWAISLGSIIVSTSIIATATACTNSNIESTVSSSFVRTQNGV
YAIYEITNWTKLDDNQKKSLQNLNFKTSVIDKDNNAEFTSSTGILRDGRV
YVKLAREPKKDDRVIIKPDDANLKKGAVYVTTLNISNIELNDGPKVQISH
SNEKNEIKSYNSAESIIYNQRWLANIWNTLSAEKDGMLLTEYNSAKHQFD
AMIKQSDFDTSKVKVEKDSNGNITKVTVSNPESNKAIPVVFMDIDETILN
NYANQNYQLLNNKAYNPKDWDAFVNDKVSKRLAGAFEFIKYVWEHGGVVM
FNSNREQENQVDPTIENLVSEGLERSLLPKWIFWMQGVDFSSDKPWANIK
KDAQGKRVKSTKEDRMNAMNKRTQGYDLSEFGSGNAVVLKTVMRIGDNFD
DFNDNASKGKLNSERVALLKEYGKLFGNFDINNKGVKYEKNQNGQMVKSD
ETWSESYVLIGGNSSYGGFEAGIAKGYYGLGKEGQAKALKDYIKQLYWEP
KSK
>UU592 conserved hypothetical ATP/GTP-binding protein
MDIINKKINWFPGHMKKATDEILKNLKNVDFFIQLVDARCPLTSSNIELL
KEVSSKPVINLANKADLSDWKKNFDNNFLLISTKKRNDKNKIIQHLYQLF
DQKIKIYQKKGLINPKFVGMIIGLPNIGKSSLINFLAPKKVLKVENRPGV
TKTQCIRQINQHFYLIDTPGIFLKNIQNERDSFVLTLINCVKKEVLELES
IVHFAYDFYLKNYRNELFIKYKMNKVLNFDDFIHHICELYNYKLTNNEFD
HVRAYENLFNDFSNGLICKVNYD
>UU480 conserved hypothetical ATP/GTP-binding protein
MIKKHIKKIVIGALSTLAFITTTVVATACAKHNNSVTKNNEPNVNVKDEI
SSSNSELNDSHYYWKAPKSDTSEGFQTIHKSMVEDGKRAFLLPGFSQSNY
LQDAIKNAKFDKNAVGFLLDTVYNANNDPSLFDGANRVASVYFKVDDAAF
LGGIAAAYMLNANQNIFATDGQLNWGGYVALNAKNTTNYLAGFALGIEWA
NKHLANKKVLQEGSSESKTWIKVNEVQASQSSAGGFDENNENAKRILKEL
ISKKADLILPVAITQMSLAVNEAISTTSHKVAIIGVDTEQENDKTINKEA
NTFKNTNISGNKNGVIRFSIVKRLGVAIEKLLENAVNGTQFQGHVNKIGD
EIDVHDKYKLGVNTVGSLVDGVVGISESAYHYLIDAFNLAQTDETNKVST
YDQLVQKIIQDPLFKSLNQDPKIDGYINPKNLANARGNEGELINGKTISP
EANGGTIYKATNGSYYYYPVAKSTYTAQNASTIFKEIWDKAKNDDDKRRL
VGLILSFAGANVKDGGYSEISYDGMLGFYAKHGIKIPKL
>UU169 unique hypothetical ATP/GTP-binding protein
MRIKLDFIECFGFYSDLVEFVAKKLPIPFNEINLLGGRSSGKTFATLDFL
SSLVAIKQQNAIYVFRQNISDAKKIFSDYLNFLDQKQLLKFAKINHSERT
VIINGWTVMFEALNETRNNINKGAKVGFRLWTQARYVFAFFEEASQLDFN
LVKNSQQSLRGTKDTQVVSIFASNPWTSEHWYIENFNNHLAENEFSIQQK
PYYEYSVVDKKLFLRSTYRANKFTSQQEIEQFEWWKDIDYSKYRVISLGL
SGSVEGAIYARSLSVMHEPYGEYDNYAMQFFGGMDWGDGTSSSSSDTACL
FGSISKENGIEILDEMVYNNNVNPLTSEQQIELVVRWFIKKQQEVNVKIV
IYIDNAHLRYFYETFNATFKRIAFQYNMYGSELVFAPAIKHAIWDRVVLV
NYMLASGKLRFSKNACPKLYKDLKNCYVVLPKTIKEDTKKERSHEHTHTI
NALEYLMCAFHLYFYAQAPAINEKGAIRYGT
>UU323 conserved hypothetical
MLSFVKELNFEINQKKYFIKIYLQPRIKYIKIKIINHQIVCLINHLKLIN
IAEEFIKNNKLKILKIYENDLKKIKYDEQSLDWIILLGIKFTTIKIKNNN
FHCQFNFQKQIIYLYDQNQNLTNTKLLYQKILIYLAEIIFPQIIKNAQNI
TTLTVKKYVFGFYKSQWGVYNKIKHTIGLSYFLVHYDQDIINYVVIHELA
HIKYQHHQKSFWDFVLKYCKNAKIYNNQLKF
>UU092 unique hypothetical membrane lipoprotein
MNKKINLNSSLAYIGFLTRLIIVKKTTYLLPIITLLITLIIGIVVGCVVK
QKTQFLIISYVMIMFNLLMTTIFASLKALNIFKDFSEDGIDILVISKPIS
RKNIVWSKIFFFVLTGIVWSLVSFLGLLIFYLISFNFAKNVNYYWILSYI
SPFICYLIFGLITSLLALKLNAKISILIPFVSFIPLLTIGIIANLVSQVQ
SQAFLRLLKQKSTNNIEAFYLNNNLDQYYLINTGFFNHKFNENQNLEIMN
AYLKTRSLATFWQVSSWILPVYQLADVFNKSDYEPFSDFIKNQVDQILYA
NNLASKQFNYQLEKNSNSLINFSINNDKSFLIPSLLKNDSQNLINNNLNQ
EVIYAIDNWKDQTIEYQKNSYTQLSSDDIVGSLKWMIIKEVLNVRSFNTY
ANNLFKTLDQKANQKQILDLISNSVQKFDFNKWNDENADLFKKDFNKLLI
KSKTEQQIYLAVSLIYYLYFNPHYTNLLKILLVDHQNNLQYKTQLKINLN
NKNYLIGGFKSYLLHQILPQENDDGIDELKKDKKIRYRYSLEQGGNYLFD
YVQQNYSFKRKQQIVYKEAYCVIWLILIFSLLIGTYYGYKRKDYR
>UU266 conserved hypothetical ATP/GTP-binding protein
MAKFIKSAHYFDQYPIDKQFEICVIGRSNVGKSSLINALANKKIARTSNT
PGRTQLVNFFDFNNFRLVDLPGYGFAKVSKEKQTDLAAIIDQYLGYRQNL
CAVFQICDINVLTNDDVEMSRYFENQKYAHFVVLNKLDKVNKSYFNNNKH
KIAKFLNISTDRLLCVSAQNNINIITLFALMKKVVIQAKQEKILSKKEEK
MSSEEEIK
>UU174 conserved hypothetical
MGKNNKYLIACDLDGTLLNNDSDISEKTIEGIKKIINQGHIFCIVTGRPL
RGSIHIYEKLGLTTLMANYNGSYISNPSDKKFAPINMTFSKDIVSAILKN
RFIAKNIVNAVVEADNVATILNSNMDLNIWKSFIDIFHVPIRDMNEKNKL
TKENDINNLIRDANALLLNVNDKALFDSMVYHIKQIAPTLAVRSWSARVD
DQFEVIEINSSFADKAMAMRYLSSYYGIPLDRCIAFGDGENDLTMLNHAG
YGFAMKNGTRPAKLLARHITKHTNVENGVVWELEYVLNENK
>UU311 ard1, N-acetyltransferase complex, probable ribosomal protein-alanine-acetyltransferase subunit
MLKNLLIRPADQKDLNDIAIFENRFFLNDCYSMRNLEEIFHNSNYQIIIV
EYEQKNIAYLIYMKSVDFNEILKIGVDENYRNLKIGSLLIDLLKQKKQNI
LLEVSDLNTNALNFYLKHGFIKQNIRKRYYANGSDAILMIWKYNQT
>UU491 era, GTP-binding protein
MVLEMIKKYGIVAIVGKPNVGKSTLINAIMKKKVSIISNKPQTTRNAVKE
IYEDDESAIIFTDTPGFHEPSNKLDLFLNHEIEISYKEANVILFVTTMDK
ELDANDFEIINLIKEANKENIILVISKAEMAKNQDQIDERIHFLKKHIAF
KDVVQISALHVINIDKLINTIKNYLHKDVVTDYFRQKAEKEDKFVITEII
REQCLLNLNHEVPHGVGVEIDESKYNQEANHWIIKASIIIEKNSHKPIII
GQNGTMIKKISMGARKQLHEIYDCHISLTIFVKVENNWRDNNNIIKSLGY
KIKK
>UU115 gph, phosphoglycolate phosphatase
MFMIILLLIIIQIRRKNKRFMTKKLIVFDFDGTIMHTHTTMSLSIIGVLE
FYNHHIPSLKEMNDLLGNLSMVNIFKKYAKHDLLNIEIEMMISKYYEIYE
SSLFMIHSYFFDGILDLIKKLKSLNNNVKLAILSNKRSSLLATMVDYYNL
RPYFDYIFGAEDVEQMKPDPSGLLKIMNNCNVDHKNTLLIGDSIADLKAA
INANCHFILVNWEPQYQKHMETIINLKPLIVKTIDELETQINHFLY
>UU272 hit, probable HIT protein
MQDCIFCKILKGEIISKIIDENEFAIAILDIQPASDGHMLIIPKKHYRNF
SLTDPIYLDGMMRLAKNMTFVLEEVFPNVLGFNYLMNSNSSAGQVIMHTH
LHIIPKQSNGRGFVFKAIKEEGDISNIDEIYKKIIIKTQKLKKSRLSKHY
MV
>UU072 hlyC, hemolysin
MIEDSQETISTQANFSVGILVILAIITLILICFSVFFSAAETAITSVTTV
KWKTESNKIKSKTITNVVYKMINNYTITLATILIGNTLVNTASSTIAGLF
FAGIMKSFSTTSNAEAIGTGIATGIITLIVLIFGEFIPKNFAKKNPIKVL
KLVAYPLNCFYILFWPLTWSLNRIFNKKSQNIITATEEELKSLIEVIRHE
GTLDSQEALIINKAILFDDILIKQKMVPWTQVVKINENKTVLQSFEIFNS
TGFSRLVVVNKNDEVVGIIYLKKIIKYLLNEPNKIIRTIMQTPLLINQKD
TLYDGLRTMQFQRIHLGIVVDNITEKNPIGIITLENITEELTGNVYDETD
NENEIKEIQIVNETTWRVDAKTNAKLFLHQYIDKDIEVNDDISMGKYISK
INKNRAFKNRQLINTPNMYIETFKDVRTNQFAFLIEKKINQS
>UU021 lip3, triacylglycerol lipase
MIMELIKTNTLNFYFEPSKSELKKGSIVFIHGLDASPHYFFLINKDLSDY
DCYFVGLPAHGLTPINNKKDLNIKVFAELFINWINEIDLKEFHLLGHSLG
AGIASLVSFIIPQRIEKLILVCPYHYQYLNPFLNKKLFNAWVLFPNPFLK
FKTDVVLKKLYIDYRNNYKTLIETRWESISREYPRIARDVLFLCLSLLNI
KINHELKMAQRNLIMPTLIMVSRHDQLIDFNLAIKVFKNNNKVNQYIFNN
SGHIPFIEEPKLFTNILLSFLEDRFVEQEENDNNDINEK
>UU015 mglA, methylgalactoside permease ATP-binding protein
MEIKTNQCPYAIEMHEITKTFLNGTVIANKDVNLFVKKNEIHAIIGENGA
GKSTLMSILFGIYKQDSGSIKINGRIVNFSSAKDASKTGIGMVHQHFKLI
DTLSVLDNVILGSEGATQLGIINRKKITKELKKIIQEYGLNINLKSKISK
ITVGQQQKTEILKLLYRDIDILIFDEPTAVLSEDEIQAFLQMLKDFKAAG
KTIIIITHKLNEIKEVADSATVIRRGHYIDSFDVKQKTIAEMAELMVGRK
LVEVKNIDPITSNEKVFEVQNLDIQSIVKKQKDIVKVKSSPKGDDVSLLS
TKNNNFINFSIRKGEIFAIAGVEGNGQSELAQIISGLLKGNKEAKIMLDN
QEIEHASIRKRYQLGLSHVPEDRHKHGLVLDDTIAMNAILQQVDDKPYSN
LGFFNNNEISKHAINIIKKYDVRGTTRGTSDARGLSGGNQQKLIIGREFE
RSHKLILLVQPTRGLDLGAIEFIHEQTLEEKRKGNAILLISYELDEILSL
ADTIAVIHNGYFISVGDRFSMTRQKIGELMAGEKI
>UU486 mnuA-2, membrane nuclease A-hypothetical
MKNNKSRKWVITISLTLLIILIASAVIGVVFYLKNKKKNDTSVNNDSYII
QNNNNSLKEQPNSTRSFLNQKTICVGHWNVLNQGGINQLKNEALAKVILK
SNVDVIALTEINSAKNNEHDDLPMRAILKELNLHKNQFDQTANWNYVLSK
NLFSKGNESQTERIGFFYKANIIKPVQEYIYKNNDNKDILFEQYFKNWND
NTKITYSRPPYAYEFQTLDNKFNFTIVASHLDSPGANEHKTSKHDHTYGN
KNLKINIKQGSKELNEAYQLGNVMDYIDRLDGNNDDLIFVGDTNIKTKNE
LGAFASLYKRNYLSNFKDDNENNKTTLAKTYLKYAQHYDKIFTSPSIKVL
NTYKYDLWSVSLTNTLLDKNWKLAFLKTYFRSLSNQQMQNIVDNWDEIAK
SNDVYIKKATSIISDHTLVAVNIKIDENDIIDEN
>UU461 obg, GTP-binding protein
MAFIDKCKIVLIAGNGGDGIVSWRRETHVPEGGPAGGNGGNGGSIWFVGN
HNETSLEFLKYKKIIRAKHGEKGDIKNQHGANAEDVFINVPLGTVVYNPI
TNEILADINIDQQKYLVAQGGLGGHGNTHFKSPFNKAPNLYELGELGENV
EVLLELKTIADIGIIGLPNAGKSTLISTFTNAKPKTANYMFTTLNPVLGT
IYRDQNRIIFADIPGLIEGAHTGVGLGHDFLKHIERCFLLIHLISLDPND
NPDIINAYETIVNELKQYKQNLVNKPIVLVANKIDQIGALENLQILKEYL
KNNQEIKIISALTNLHVDNMLDDVIKIYFAQKKIYEQRLKEQLPVDQILK
WTSDIPKSKELDKTIEIIKVDDHIFEVFGEYLKYWAHRIPLKTQDNLIRF
NQKLQSINFNQQLLQAGAVAGDSIKIYDITLEFEE
>UU457 pheT, phenylalanine-tRNA synthetase beta chain
MILSLNLLHKISPKLKKIPLNELCAALMDLGCEVETINSIKPSTNLVFAK
VLEKTRHPNANHLNLVKVKANQKVYEIVCGANNFSVHNWVVLAKLNAELA
NGLKITPRELRGYVSNGMLCAYSEINPQATSFLTSTDLDGILVLDDNYDH
YKTPNQIFNLDDVILDLSIPSNRNDLNGYFWIAKELCAYFDFEYVVDATI
NHRPHKEIIDVRILSDDVNSYGIIEVKNIQNYILKWNTKSILINNQIKVL
NNFADNMNFLTLLTANPLHAFDARKISGQIVVKNAEEDAILLGLDQKEYL
IKKGDLIIVDDQKILALAGIIGSNDSKIDATSTTAYIECANFNPMLIANT
ARRLKINTAAAMRFSKPLTNYVTKVTLKKLLANFKSDAKLIYYFKHSVHN
VIKNKINQVSDFVGAEIDLDTAQTFLKRLGYKINKSNLITPSHRYDVLNE
FDVYEDIMKKISIQEIKPQPISFDILNFENNLAYDFEKKVSDFLVDQGLF
ECKTYNLKNQTQAHEFNFFNFKQAYEINNPTSNMRSHLKLNNLNSLLEVL
EYNQNQKNELENIFEISKINPVDSSQQTVLSIILCKPLINSKINDSLIVN
NFVTTKALLHALLTKLNIDYAYDKNHVVNELYDNNQLALINANKQVFGFI
GQLKNQVKKTYGLSNDIFIINLNLTSYLNQKQVITKVIKPSMYHDVIRDI
SVKLASDVDLNNIIANIKKIKNIRKVEISDLYIKDDGIIYTFKYYINDHL
SNLSSEQIIIIEQEVNNYLKQF
>UU216 pkn, serine/threonine kinase
MREEIKTNSILNYKYKVVKHLADGGFSKVYLCCFLSDETKFIVIKVLDIN
DEKQQMVVYDELRISNLIKNSDSDKKNYIMEYYEYFETGSLENNDKRIYI
VFEYIEGLTLREYLDEFKTITYVKAVEIIRQVALGVSFFHSCNPQIIHRD
LKPENCMINKTLTKIKIIDYGAASVFYNREDLTKDQEIKCTIIYASPKLL
SLGQKVKEQANKGLNKRALSLINDALGVSYDIHSLGVMLYELITGTNPFS
EHTITDDRDYLEKWITYDVEPLSLINKTIPKGIDNILMRCFAWKKEDNKL
LYKDIYTLIDDLSNVMDPESNLNQEYIKPLNKLRIYRKNLAGLYEIKEKD
RKWYLQKWFIILISCLSVILIILLIIILFFKKSGAI
>UU014 rbsC-1, ribose/galactose ABC transporter (N-term domain)
MLKFKTLLSYDSFLKGQERKTITKKFLSTVFAIFVAIVVSAILVGILGYN
IRDFFIRLFTKWIGSPDIYLTKVAILGIAALSFIFAFKAGLFNIGISGQM
LGSGLIMLLVVKNMQIANINMPNVLGQFFLLIIAMLAGAMFAVFIGILKV
FLKINEVVSSILLNWIMFYITRYVVFTAQSKMYNPTPDQVGSRSIPFADN
YSLFHLASGYGYLFALLIFISLSIIIWVILKYTVFGHKVLSVGKSFDAAK
YAGYRTKIISLATFAISGALAGALAMVNYTSTTTNAIVISQAADALPTQG
YDGIAMGLISLAHPLATIPVSFLMGLLQQSADNLGGSFPQDLSGIIISFV
MLGAAMFILFERISPVYWIYHLIYTYKGKDYYRDYENKNNNIISEYKAIY
SEINKKRNQYLQELKKLRKELDQFKNHEQYNKVNQQYEYTISYIKTTYNA
WLKVEYDKYLKQLKNNAMQLKKHLIIERATLVYYPEINTTRKIKNKLKHF
ENISAKKLSRIKDKIHNEDFLIKNLVAKEISKYAQSKSFDYNKLKYLLQE
YENNNSVLTTELVNELSLVLKDEQAQLMFSEFKQASFENNLDHMIDLKNQ
IMTYINSLLDSRLEQLSITLKSKNLVHDEQMDKIILLLNPNDKILNKIII
SRNKHLENYTKEITKLELRNISQDDEIKKNTKQRSSSYLTKHYEKTKQHI
NKINLDQEQKLLLEDWLTTAYQKAIINQQNMKEVIS
>UU013 rbsC-2, ribose/galactose ABC transporter
MPSLSLINDASIYAAILILGALSGFFCERVGIANISINGQMIIGALVFTL
FSTIIYKYMGTKTETEYTFIVCLIIAGILTIPTSLLFGFLTIKLKTNQII
AGTAINLLASGVATFVTYPLGDKIADKTSLSSDYLGLMKIGDGINTIYIG
SILILIAVVLITIGLMIMMKKTPFGLRLYAIGENPNAADAQGINVYKYQW
IAVSISGFIAGIGGGLYMYASRSPFAGEVGGIGFLALAILIAGAWRIPLI
AVVSIAFAVITKTFSQIDKIPQEIGKLIPYVITLIALISFSKYSVAPKNV
GIPFDKTKR
>UU018 thdF, GTP-binding protein in thiophene and furan oxidation
MSTIVALATAPMNCAIHIIRVSGPKAFEIINKISTIKIKKETFKIWYTIL
KDDNQILDEVLINTFVAPKTFTGEDLVEINCHGGIVVANLIIKTLIKYGC
QPAQRGEFSRRALLNKKMDLSKIEAINNLVNAKNELSVKGVIGALLGRVS
QSIAEFRHELFMIIGQIEVNIDYPEYDDVEQVDAIILKQRLLSLDKKITK
IIDQSKKFLPINKGIRVLIIGKPNVGKSTLLNALCNEQKAIVTDIPGTTR
DVIESSINIDNITLNILDTAGIHLTNDFVENLGINKAKALIDKVDLILYL
IPANEQQDLELYDLIKKQKHLLVYTKKDLVDQYDDKQIYINAKNNDIQSL
IDEIKKLFYVQEFDNANIDVLQSQRQIGILENVHYLINNAILNLEKGDTL
DLIVADLEFCNLRLNELLGISSEYDFLDDLFKNFCIGK